🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

17 recruiting trials

for Gynecological Malignant Tumor

Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer NCT05647109n/a1 site📍 Beijing Peking University People's Hospital · Tests: No intervention Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment NCT06816095n/a1 site📍 Las Palmas Bernardino Clavo, MD, PhD A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB NCT06781151n/a2 sites📍 Guangzhou📍 Shenzhen Sun Yat-sen University Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy NCT04957511n/a1 site📍 Orlando Viome Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract NCT05478876NA1 site📍 Pavia CNAO National Center of Oncological Hadrontherapy · Tests: carbon ion radiation therapy CIRT A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies NCT05803018Phase 1, Phase 21 site📍 Shanghai Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-B01D1 A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors NCT06769152Phase 21 site📍 Ji'nan Shanghai Henlius Biotech · Tests: HLX43 A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib NCT05512208Phase 24 sites📍 Orlando📍 New Orleans📍 Albuquerque University of Oklahoma · Tests: Avutometinib (VS-6766) + defactinib Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities NCT07572396Phase 21 site📍 Shatin Amplexd Therapeutics, Inc. · Tests: EGCG and Quinine Sulfate Vaginal Suppository, Placebo Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies NCT07434284EARLY Phase 11 site📍 Shanghai Obstetrics & Gynecology Hospital of Fudan University · Tests: cCTL treatment Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies NCT05457595NA1 site📍 Pavia CNAO National Center of Oncological Hadrontherapy · Tests: carbon ion radiation therapy Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases. NCT06574087NA1 site📍 Gdynia PCK Marine Hospital in Gdynia · Tests: hrHPV test and cytology A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors NCT07448922Phase 22 sites📍 Chongqing📍 Shanghai Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Tests: SKB518 for injection, Carboplatin (AUC 5), Bevacizumab, SKB518 for injection Evaluation of the Subjectively Perceived Pelvic Floor Function in Patients With Gynecological Tumors and Breast Cancer Under Systemic Tumor Therapy Using a Validated Questionnaire NCT04655066n/a1 site📍 Wiesbaden St. Josefs-Hospital Wiesbaden GmbH Identifying Genetic Targets in Gynecological Tumors NCT07169396n/a1 site📍 Reggio Emilia Azienda USL Reggio Emilia - IRCCS · Tests: RNA extraction and gene expression Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers NCT06492070Phase 23 sites📍 Atlanta📍 Atlanta📍 Atlanta Emory University · Tests: Best Practice, Cilostazol, Cryocompression Therapy, Paclitaxel, Quality-of-Life Assessment Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer NCT06855524Phase 21 site📍 Scottsdale Mayo Clinic · Tests: Biospecimen Collection, Oligo-fucoidan, Placebo Administration, Questionnaire Administration
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy